Qatar v. Ecuador to kick off FIFA World Cup 2022™ on 20 NovemberRead more Webb Fontaine Announces Launch of Niger National Single Window (NNSW) to Bolster TradeRead more Ethiopia: Loan from United Nations Fund Allows Food and Agriculture Organization (FAO) to Scale Up Fertilizers for Farmers in TigrayRead more How Choosing the Right Printer Helps Small Businesses and Content Creators to Save Time, Maximise Productivity and Achieve GrowthRead more Eritrea: World Breastfeeding WeekRead more Eritrean community festival in Scandinavian countriesRead more IOM: Uptick in Migrants Heading Home as World Rebounds from COVID-19Read more Network International & Infobip to offer WhatsApp for Business Banking Services to Financial Institution Clients across AfricaRead more Ambassador Jacobson Visits Gondar in the Amhara Region to Show Continued U.S. Support for the Humanitarian and Development Needs of EthiopiansRead more Voluntary Repatriation of Refugees from Angola to DR Congo ResumesRead more

Cherokee Nation reaches settlement with US opioid distributors

show caption
The opioid crisis in America has left more than half a million people dead./AFP
Print Friendly and PDF

Sep 29, 2021 - 06:51 AM

WASHINGTON — The Cherokee Nation said Tuesday that pharmaceutical distributors have agreed to pay it $75 million to end lawsuits stemming from the opioid crisis in America.

The out of court settlement with AmerisourceBergen, Cardinal Health and McKesson is the first of its kind involving a Native American community in the United States.

“Today’s settlement will make an important contribution to addressing the opioid crisis in the Cherokee Nation Reservation; a crisis that has disproportionately and negatively affected many of our citizens,” Cherokee Nation Principal Chief Chuck Hoskin said in a statement.

The money to be paid out over six and a half years “will enable us to increase our investments in mental health treatment facilities and other programs to help our people recover,” Hoskin said.

The Cherokee Nation sued opioid distributors in 2017, accusing them of closing their eyes to suspicious orders of the highly addictive painkillers.

It said it plans to pursue lawsuits it has already filed against pharmacies such as Walmart, Walgreens and CVS, which could lead to trials within a year.

The opioid crisis in the United States has caused more than half a million overdose deaths in 20 years.

It has also prompted a wave of lawsuits from victims of the drugs and from cities, counties and states grappling with recovery and prevention efforts.

Opioid manufacturers like Purdue Pharma were the first to be targeted. They were accused of encouraging, through aggressive marketing tactics, free-wheeling prescription of their products while hiding how addictive they are.

Purdue Pharma agreed to pay out $4.5 billion to victims of the drugs and states, counties and other entities in exchange for a degree of immunity for its owners, the Sackler family.

Another manufacturer, Johnson & Johnson, and the distributors AmerisourceBergen, Cardinal Health and McKesson have agreed to pay out a total of $26 billion dollars in damages.

LMBCHEALTH.COM uses both Facebook and Disqus comment systems to make it easier for you to contribute. We encourage all readers to share their views on our articles and blog posts. All comments should be relevant to the topic. By posting, you agree to our Privacy Policy. We are committed to maintaining a lively but civil forum for discussion, so we ask you to avoid personal attacks, name-calling, foul language or other inappropriate behavior. Please keep your comments relevant and respectful. By leaving the ‘Post to Facebook’ box selected – when using Facebook comment system – your comment will be published to your Facebook profile in addition to the space below. If you encounter a comment that is abusive, click the “X” in the upper right corner of the Facebook comment box to report spam or abuse. You can also email us.